netFormulary
 Report : A-Z CDF items in Formulary 17/06/2021 00:15:32
[Back]
 
Section Status CDF Name
08.03.04.01 Formulary Cancer Drugs Fund Abemaciclib Verzenios
08.03.04.02 Formulary Cancer Drugs Fund Abiraterone 
08.01.05 Formulary Cancer Drugs Fund Aflibercept Zaltrap
08.01.05 Formulary Cancer Drugs Fund Atezolizumab 
08.01.05 Formulary Cancer Drugs Fund Avelumab  Bavencio
08.01.05 Formulary Cancer Drugs Fund Axicabtagene ciloleucel 
08.01.01 Formulary Cancer Drugs Fund Bendamustine 
08.01.05 Formulary Cancer Drugs Fund Bevacizumab Avastin
08.01.05 Formulary Cancer Drugs Fund Bortezomib 
08.01.05 Formulary Cancer Drugs Fund Bosutinib 
08.01.05 Formulary Cancer Drugs Fund Brentuximab vedotin Adcetris
08.01.05 Formulary Cancer Drugs Fund Cabazitaxel 
08.01.05 Formulary Cancer Drugs Fund Cabozantinib 
08.02.04 Formulary Cancer Drugs Fund Cemiplimab Libtayo®
08.01.05 Formulary Cancer Drugs Fund Cetuximab 
08.01.03 Non Formulary Cancer Drugs Fund Clofarabine Evoltra
08.01.05 Formulary Cancer Drugs Fund Crizotinib 
08.01.05 Formulary Cancer Drugs Fund Dabrafenib Tafinlar
08.01.05 Formulary Cancer Drugs Fund Daratumumab Darzalex
08.02.04 Formulary Cancer Drugs Fund Durvalumab Imfinzi
08.01.05 Formulary Cancer Drugs Fund Entrectinib 
08.01.05 Formulary Cancer Drugs Fund Eribulin Halaven
08.01.05 Formulary Cancer Drugs Fund Ibrutinib Imbruvica
08.01.05 Formulary Cancer Drugs Fund Idelalisib 
08.01.05 Formulary Cancer Drugs Fund Larotrectinib 
08.02.04 Formulary Cancer Drugs Fund Lenalidomide 
08.01.03 Non Formulary Cancer Drugs Fund Nelarabine Atriance
08.01.05 Formulary Cancer Drugs Fund Niraparib Zejula®
08.01.05 Formulary Cancer Drugs Fund Olaparib 
08.01.05 Formulary Cancer Drugs Fund Pablociclib Ibrance
08.01.05 Non Formulary Cancer Drugs Fund Panitumumab Vectibix
08.01.05 Formulary Cancer Drugs Fund Pembrolizumab Keytruda
08.01.03 Formulary Cancer Drugs Fund Pemetrexed 
08.01.05 Formulary Cancer Drugs Fund Pertuzumab Perjeta
08.02.04 Formulary Cancer Drugs Fund Pomalidomide Imnovid
08.01.05 Formulary Cancer Drugs Fund Ponatinib Iclusig
08.01.05 Formulary Cancer Drugs Fund Regorafenib Stivarga
08.01.05 Formulary Cancer Drugs Fund Rucaparib 
08.01.05 Formulary Cancer Drugs Fund Ruxolitinib 
08.01.05 Formulary Cancer Drugs Fund Sorafenib 
08.01.05 Formulary Cancer Drugs Fund Sunitinib 
08.01.05 Formulary Cancer Drugs Fund Tisagenlecleucel Kymriah
08.01.05 Formulary Cancer Drugs Fund Trastuzumab emtansine Kadcyla
08.01.05 Non Formulary Cancer Drugs Fund Vandetanib Caprelsa
08.01.05 Non Formulary Cancer Drugs Fund Vismodegib Erivedge
Sunderland Joint Formulary